Jerusalem: The biotech capital

20.07.2011                      18.Tammus, 5771

Bio-Forschung:

Jerusalem: The biotech capital

Merck and Pfizer consider opening research centers in the city.

A number of major international biomedical companies are negotiating to open research and development centers in Jerusalem. Among the big names in contact with the Jerusalem Development Authority are Pfizer, Merck and Bristol-Myers Squibb.
The CEO of the JDA, Moty Hazan, and Chen Levin, the executive director of the Bio-Jerusalem project confirmed the contacts….